Metraipolis › archive › dc_e28b3fdc358d
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK — Europe PMC PMID:41800807
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41800807
- DOI
- 10.1530/ec-25-0903
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T02:11:37.179Z
- SHA-256 of the archived text
8fbf9cc910c762879e79e5e98825b65bc99591c6f3a93e38a6f3b6aa84a373ed- Stable URL of this page
https://metraipolis.com/documento/dc_e28b3fdc358d
How to cite
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK — Europe PMC PMID:41800807 — Europe PMC (en), https://europepmc.org/article/MED/41800807 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e28b3fdc358d (Metraipolis archive dc_e28b3fdc358d, sha256 8fbf9cc910c762879e79e5e98825b65bc99591c6f3a93e38a6f3b6aa84a373ed)
BibTeX
@misc{dce28b3fdc358d,
title = {Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK — Europe PMC PMID:41800807},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41800807},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e28b3fdc358d; sha256 8fbf9cc910c762879e79e5e98825b65bc99591c6f3a93e38a6f3b6aa84a373ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800807. Agents can read the archived copy with the MCP tool read_document.